74.64
前日終値:
$72.65
開ける:
$72.75
24時間の取引高:
4.96M
Relative Volume:
1.15
時価総額:
$43.82B
収益:
$5.69B
当期純損益:
$1.41B
株価収益率:
10.69
EPS:
6.9828
ネットキャッシュフロー:
$577.90M
1週間 パフォーマンス:
+0.95%
1か月 パフォーマンス:
-0.74%
6か月 パフォーマンス:
+4.35%
1年 パフォーマンス:
+9.01%
Edwards Lifesciences Corp Stock (EW) Company Profile
名前
Edwards Lifesciences Corp
セクター
電話
(949) 250-2500
住所
ONE EDWARDS WAY, IRVINE, CA
EW を他の銘柄と比較する
株式 | 価格 | 時価総額 | 収益 | 当期純利益 | 現金流量 | EPS |
---|---|---|---|---|---|---|
![]()
EW
Edwards Lifesciences Corp
|
74.64 | 42.65B | 5.69B | 1.41B | 577.90M | 6.9828 |
![]()
ABT
Abbott Laboratories
|
128.54 | 222.13B | 43.84B | 13.94B | 6.78B | 7.9979 |
![]()
BSX
Boston Scientific Corp
|
99.24 | 144.89B | 18.49B | 2.50B | 3.49B | 1.6801 |
![]()
SYK
Stryker Corp
|
374.42 | 141.17B | 23.82B | 2.92B | 4.02B | 7.5574 |
![]()
MDT
Medtronic Plc
|
95.78 | 121.91B | 34.20B | 4.69B | 5.30B | 3.6218 |
Edwards Lifesciences Corp Stock (EW) Upgrades & Downgrades
日付 | アクション | アナリスト | 評価の変更 |
---|---|---|---|
2025-10-08 | ダウングレード | Oppenheimer | Outperform → Perform |
2025-10-07 | アップグレード | Evercore ISI | In-line → Outperform |
2025-07-29 | アップグレード | BTIG Research | Neutral → Buy |
2025-04-24 | アップグレード | Piper Sandler | Neutral → Overweight |
2025-01-30 | アップグレード | Stifel | Hold → Buy |
2025-01-16 | ダウングレード | Wolfe Research | Peer Perform → Underperform |
2024-12-16 | アップグレード | BofA Securities | Neutral → Buy |
2024-10-11 | 再開されました | Morgan Stanley | Equal-Weight |
2024-09-18 | ダウングレード | Jefferies | Buy → Hold |
2024-07-31 | アップグレード | Daiwa Securities | Neutral → Outperform |
2024-07-29 | アップグレード | Wolfe Research | Underperform → Peer Perform |
2024-07-25 | ダウングレード | BofA Securities | Buy → Neutral |
2024-07-25 | ダウングレード | JP Morgan | Overweight → Neutral |
2024-07-25 | ダウングレード | Robert W. Baird | Outperform → Neutral |
2024-07-25 | ダウングレード | TD Cowen | Buy → Hold |
2024-07-25 | ダウングレード | Truist | Buy → Hold |
2024-05-30 | 開始されました | Goldman | Buy |
2024-05-22 | アップグレード | Citigroup | Neutral → Buy |
2024-05-14 | アップグレード | Deutsche Bank | Hold → Buy |
2024-03-07 | アップグレード | BofA Securities | Neutral → Buy |
2024-02-02 | アップグレード | Wells Fargo | Equal Weight → Overweight |
2024-01-04 | ダウングレード | Evercore ISI | Outperform → In-line |
2023-12-11 | ダウングレード | Citigroup | Buy → Neutral |
2023-11-28 | ダウングレード | Wolfe Research | Peer Perform → Underperform |
2023-09-26 | アップグレード | Oppenheimer | Perform → Outperform |
2023-07-19 | 開始されました | Robert W. Baird | Outperform |
2023-05-30 | 再開されました | Morgan Stanley | Overweight |
2023-03-29 | 開始されました | UBS | Neutral |
2023-03-08 | ダウングレード | Wells Fargo | Overweight → Equal Weight |
2023-02-06 | ダウングレード | Raymond James | Outperform → Mkt Perform |
2023-01-31 | ダウングレード | Bernstein | Outperform → Underperform |
2023-01-30 | ダウングレード | Piper Sandler | Overweight → Neutral |
2022-12-06 | ダウングレード | Stifel | Buy → Hold |
2022-10-28 | ダウングレード | Oppenheimer | Outperform → Perform |
2022-10-26 | 開始されました | Mizuho | Buy |
2022-10-18 | 開始されました | Barclays | Overweight |
2022-10-12 | 開始されました | Jefferies | Buy |
2022-07-29 | ダウングレード | Canaccord Genuity | Buy → Hold |
2022-04-13 | 開始されました | Truist | Buy |
2022-04-06 | 開始されました | Wolfe Research | Outperform |
2022-03-16 | アップグレード | Bernstein | Mkt Perform → Outperform |
2022-03-02 | 再開されました | BofA Securities | Neutral |
2022-02-02 | アップグレード | UBS | Neutral → Buy |
2022-01-27 | 繰り返されました | Citigroup | Buy |
2022-01-27 | 繰り返されました | Evercore ISI | Outperform |
2022-01-27 | 繰り返されました | Raymond James | Outperform |
2022-01-27 | 繰り返されました | Stifel | Buy |
2022-01-27 | 繰り返されました | UBS | Neutral |
2021-12-17 | アップグレード | JP Morgan | Neutral → Overweight |
2021-12-15 | アップグレード | Citigroup | Neutral → Buy |
2021-12-10 | 開始されました | RBC Capital Mkts | Outperform |
2021-12-06 | アップグレード | Wells Fargo | Equal Weight → Overweight |
2021-07-30 | 繰り返されました | Canaccord Genuity | Buy |
2021-07-30 | 繰り返されました | Deutsche Bank | Hold |
2021-07-30 | 繰り返されました | Jefferies | Buy |
2021-07-30 | 繰り返されました | Morgan Stanley | Overweight |
2021-07-30 | 繰り返されました | Oppenheimer | Outperform |
2021-07-30 | 繰り返されました | Stifel | Buy |
2021-07-30 | 繰り返されました | UBS | Neutral |
2021-07-30 | 繰り返されました | Wells Fargo | Equal Weight |
2021-05-25 | 開始されました | Barclays | Overweight |
2021-04-15 | 開始されました | Atlantic Equities | Neutral |
2021-04-05 | アップグレード | Evercore ISI | In-line → Outperform |
2020-12-16 | ダウングレード | Citigroup | Buy → Neutral |
2020-12-11 | 繰り返されました | Canaccord Genuity | Buy |
2020-09-11 | 開始されました | Wolfe Research | Underperform |
2020-04-28 | ダウングレード | Wells Fargo | Overweight → Equal Weight |
2020-04-17 | アップグレード | SVB Leerink | Mkt Perform → Outperform |
2020-03-05 | 開始されました | Citigroup | Buy |
2020-02-13 | 開始されました | Goldman | Neutral |
2020-02-06 | 再開されました | BTIG Research | Neutral |
2020-01-10 | 開始されました | Oppenheimer | Outperform |
2020-01-02 | ダウングレード | Evercore ISI | Outperform → In-line |
2019-10-24 | 繰り返されました | Canaccord Genuity | Buy |
2019-09-23 | 開始されました | Piper Jaffray | Overweight |
2019-07-24 | 繰り返されました | BofA/Merrill | Buy |
2019-03-18 | 繰り返されました | Canaccord Genuity | Buy |
2019-01-18 | アップグレード | BofA/Merrill | Neutral → Buy |
2019-01-03 | 開始されました | Deutsche Bank | Hold |
2018-11-28 | 開始されました | UBS | Neutral |
2018-10-16 | 開始されました | Barclays | Underweight |
2018-10-02 | ダウングレード | BofA/Merrill | Buy → Neutral |
2018-10-02 | ダウングレード | Guggenheim | Buy → Neutral |
すべてを表示
Edwards Lifesciences Corp (EW) 最新ニュース
Edwards Lifesciences (EW) Added to Evercore ISI's Tactical Outpe - GuruFocus
Robust TAVR Growth to Drive Edwards Lifesciences' Q3 Earnings - Yahoo Finance
Analysts Offer Insights on Healthcare Companies: GoodRx Holdings (GDRX) and Edwards Lifesciences (EW) - The Globe and Mail
Using Python tools to backtest Edwards Lifesciences Corporation strategiesQuarterly Earnings Summary & Real-Time Volume Analysis - newser.com
EW Investor News: Rosen Law Firm Investigates Breaches of Fiduciary Duties by the Directors and Officers of Edwards Lifesciences Corporation – EW - GlobeNewswire Inc.
How high can Edwards Lifesciences Corporation stock goIndex Update & Proven Capital Preservation Methods - newser.com
Is Edwards Lifesciences Corporation stock a good choice for value investorsVolume Spike & Community Verified Swing Trade Signals - newser.com
Leerink Partners Adjusts Price Target on Edwards Lifesciences to $84 From $85, Maintains Market Perform Rating - MarketScreener
Mizuho Adjusts Price Target on Edwards Lifesciences to $90 From $95, Maintains Outperform Rating - MarketScreener
What is the fair value of Edwards Lifesciences Corporation stock nowWeekly Market Outlook & Target Return Focused Stock Picks - newser.com
Aberdeen Group plc Increases Position in Edwards Lifesciences Corporation $EW - MarketBeat
OFI Invest Asset Management Has $26.57 Million Stake in Edwards Lifesciences Corporation $EW - MarketBeat
Stonehage Fleming Financial Services Holdings Ltd Makes New Investment in Edwards Lifesciences Corporation $EW - MarketBeat
Callan Family Office LLC Boosts Stock Position in Edwards Lifesciences Corporation $EW - MarketBeat
EW Investor News: Rosen Law Firm Investigates Breaches of - GlobeNewswire
Real time breakdown of Edwards Lifesciences Corporation stock performanceGDP Growth & Weekly Market Pulse Updates - newser.com
Ranking Edwards Lifesciences Corporation among high performing stocks via toolsPortfolio Risk Summary & Low Drawdown Momentum Trade Ideas - newser.com
Blair William & Co. IL Has $30.51 Million Holdings in Edwards Lifesciences Corporation $EW - MarketBeat
What machine learning models say about Edwards Lifesciences CorporationWeekly Trade Report & Weekly Breakout Watchlists - newser.com
Visual trend scoring systems applied to Edwards Lifesciences Corporation2025 Analyst Calls & Reliable Volume Spike Alerts - newser.com
Vontobel Holding Ltd. Reduces Stock Holdings in Edwards Lifesciences Corporation $EW - MarketBeat
Edwards Lifesciences (EW): Assessing Valuation Following Recent Share Price Decline - Yahoo Finance
Edwards Lifesciences (NYSE:EW) Given "Hold (C)" Rating at Weiss Ratings - MarketBeat
Here's What to Expect From Edwards Lifesciences’ Next Earnings Report - MSN
Edwards Lifesciences Leads Healthcare Stocks in S&P 500 - Kalkine Media
Edwards Lifesciences' Long-Term Plan Raises Concerns Amid 'Structural' Risks, Oppenheimer Says - MarketScreener
Edwards Lifesciences (NYSE:EW) Upgraded at Evercore ISI - MarketBeat
Edwards Lifesciences stock downgraded by Oppenheimer on structural concerns - Investing.com
Oppenheimer Downgrades Edwards Lifesciences to Market Perform From Outperform - MarketScreener
Edwards Lifesciences Corporation $EW Shares Bought by Mirova US LLC - MarketBeat
Shell Asset Management Co. Acquires 19,014 Shares of Edwards Lifesciences Corporation $EW - MarketBeat
Edwards Lifesciences (EW) Upgraded by Evercore ISI - GuruFocus
Edwards Lifesciences (EW) Receives Analyst Upgrade and Price Tar - GuruFocus
Edwards Lifesciences stock maintains Overweight rating ahead of PARTNER 3 data - Investing.com
Edwards Lifesciences stock upgraded by Evercore ISI on reduced competition - Investing.com
Evercore ISI Upgrades Edwards Lifesciences to Outperform From In Line, Adjusts PT to $88 From $80 - MarketScreener
Seamount Financial Group Inc. Invests $259,000 in Edwards Lifesciences Corporation $EW - MarketBeat
QRG Capital Management Inc. Trims Stock Position in Edwards Lifesciences Corporation $EW - MarketBeat
Here's What To Expect From Edwards Lifesciences’ Next Earnings Report - Barchart.com
Edwards Lifesciences Corporation $EW Shares Bought by Comprehensive Financial Consultants Institutional Inc. - MarketBeat
Edwards Lifesciences Corporation (NYSE:EW) Short Interest Update - MarketBeat
Edwards Lifesciences Corporation $EW Shares Bought by Mirae Asset Global Investments Co. Ltd. - MarketBeat
EW Investor News: If You Have Suffered Losses in Edwards - GlobeNewswire
Edwards Lifesciences Corporation $EW Shares Sold by OLD National Bancorp IN - MarketBeat
Hilltop National Bank Purchases Shares of 8,856 Edwards Lifesciences Corporation $EW - MarketBeat
Lbp Am Sa Takes Position in Edwards Lifesciences Corporation $EW - MarketBeat
River Street Advisors LLC Buys Shares of 5,240 Edwards Lifesciences Corporation $EW - MarketBeat
Cooper Financial Group Makes New $373,000 Investment in Edwards Lifesciences Corporation $EW - MarketBeat
17,034 Shares in Edwards Lifesciences Corporation $EW Bought by USA Financial Formulas - MarketBeat
What high frequency data says about Edwards Lifesciences CorporationJuly 2025 WrapUp & Entry Point Strategy Guides - newser.com
Ninety One SA PTY Ltd Sells 5,206 Shares of Edwards Lifesciences Corporation $EW - MarketBeat
Edwards Lifesciences Corp (EW) 財務データ
収益
当期純利益
現金流量
EPS
大文字化:
|
ボリューム (24 時間):